0QF:ETR
Moderna Inc
175,04 €
arrow_upward
+1,97%(+3,38) 1D
8 tet, 5:35:47 m.d., GMT+2 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për 0QF...
Hap
172,72 €
I lartë
178,40 €
I ulët
172,32 €
Kapitalizimi i tregut
77,99 mld
Vëllimi mesatar
29,64 mijë
Vëllimi
14,40 mijë
Maksimumi 52-javor
188,30 €
Minimumi 52-javor
19,37 €
Numri i punonjësve
5 mijë
Hap
172,72 €
I lartë
178,40 €
I ulët
172,32 €
Kapitalizimi i tregut
77,99 mld
Vëllimi mesatar
29,64 mijë
Vëllimi
14,40 mijë
Maksimumi 52-javor
188,30 €
Minimumi 52-javor
19,37 €
Numri i punonjësve
5 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
AD HOC NEWS
·
2 orë më parë
Moderna stock costs EUR 173.65 with a P/ E of minus 24.4
Yahoo Finance
·
8 orë më parë
Moderna's Nasdaq-100 Entry: What Does It Mean for the Stock?
The Motley Fool
·
16 orë më parë
Axsome Therapeutics vs. Moderna: Which Biotech Stock Is a Better Buy in 2026?
GuruFocus
·
22 orë më parë
Moderna (MRNA) Shares Rise 4.8% Despite Broad Market Weakness on October 7, 2026
Profili
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
The company's commercial products are the Moderna COVID-19 vaccine sold under the brand names Spikevax and Mnexspike, a respiratory syncytial virus vaccine sold under the brand name Mresvia, and an influenza vaccine sold under the brand name Mflusiva. The company has 44 treatment and vaccine candidates, of which 37 have entered clinical trials. Candidates include possible vaccines for influenza, HIV, Epstein–Barr virus, the Nipah virus, chikungunya, human metapneumovirus, varicella zoster virus, as well as a cytomegalovirus vaccine, a Zika virus vaccine funded by the Biomedical Advanced Research and Development Authority, and three cancer vaccines.
In May 2026, Time ranked Moderna first in their list of the World's Most Impactful Companies. Wikipedia
Rreth Moderna Inc
Drejtori ekzekutivStephane Bancel
Punonjësit4,7 mijë
Themeluar mësht 2010
Selia-
Sektori-
Uebsajtimodernatx.com